Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DrAid™ for Liver Segmentation

K-Number: K241543 · 2024-12-06

Decision Date2024-12-06
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

DrAid™ for Liver Segmentation is a medical device manufactured by Vinbrain Joint Stock Company. It received FDA 510(k) clearance on 2024-12-06 under approval number K241543. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DrAid™ for Liver Segmentation?

DrAid™ for Liver Segmentation is a medical device that received FDA 510(k) clearance on 2024-12-06. It is manufactured by Vinbrain Joint Stock Company. The 510(k) number is K241543.

When was DrAid™ for Liver Segmentation approved by the FDA?

DrAid™ for Liver Segmentation received FDA 510(k) clearance on 2024-12-06, under approval number K241543.

What company makes DrAid™ for Liver Segmentation?

DrAid™ for Liver Segmentation is manufactured by Vinbrain Joint Stock Company.

What is the FDA product code for DrAid™ for Liver Segmentation?

The FDA product code for DrAid™ for Liver Segmentation is QIH.

Other Devices by Vinbrain Joint Stock Company

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.